NM_032387.5(WNK4):c.1477-13A>G AND not provided

Germline classification:: Benign (2 submissions)
Last evaluated:: Jan 25, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001613040.9

Allele description [Variation Report for NM_032387.5(WNK4):c.1477-13A>G]

NM_032387.5(WNK4):c.1477-13A>G

Gene:

WNK4:WNK lysine deficient protein kinase 4 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17q21.2

Genomic location:

Preferred name:

NM_032387.5(WNK4):c.1477-13A>G

HGVS:

NC_000017.11:g.42787265A>G
NG_016227.1:g.11635A>G
NM_001321299.2:c.469-13A>G
NM_032387.5:c.1477-13A>GMANE SELECT
NC_000017.10:g.40939283A>G
NM_032387.4:c.1477-13A>G

Links:

dbSNP: rs61754357

NCBI 1000 Genomes Browser:

rs61754357

Molecular consequence:

NM_001321299.2:c.469-13A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_032387.5:c.1477-13A>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

hypothetical protein BGHDH14_bgh03896 [Blumeria hordei DH14]
hypothetical protein BGHDH14_bgh03896 [Blumeria hordei DH14]
gi|528297181|emb|CCU76870.1|

Protein
PREDICTED: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 isoform X2 [Fu...
PREDICTED: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 isoform X2 [Fulmarus glacialis]
gi|697017530|ref|XP_009586355.1|

Protein
FYVE and coiled-coil domain-containing protein 1 isoform X1 [Mus musculus]
FYVE and coiled-coil domain-containing protein 1 isoform X1 [Mus musculus]
gi|1720430337|ref|XP_030099937.1|

Protein
PREDICTED: Mus musculus FYVE and coiled-coil domain containing 1 (Fyco1), transc...
PREDICTED: Mus musculus FYVE and coiled-coil domain containing 1 (Fyco1), transcript variant X3, mRNA
gi|1907195209|ref|XM_036154635.1|

Nucleotide
RecName: Full=Zinc finger CCCH-type antiviral protein 1; AltName: Full=ADP-ribos...
RecName: Full=Zinc finger CCCH-type antiviral protein 1; AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 13; Short=ARTD13; AltName: Full=Inactive Poly [ADP-ribose] polymerase 13; Short=PARP13; AltName: Full=Zinc finger antiviral protein; Short=ZAP; Short=rZAP
gi|47117346|sp|Q8K3Y6.1|ZCCHV_RAT

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001836929	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Benign (May 9, 2021)	germline	clinical testing	Citation Link,
SCV002488068	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Jan 25, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001836929

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Benign
(May 9, 2021)

germline

clinical testing

Citation Link,

SCV002488068

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Jan 25, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From GeneDx, SCV001836929.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002488068.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine